# Cabot Corporation (CBT) â€“ Financial Analysis

**Date:** November 4, 2025  
**Analysis Period:** Q4 FY2025 (Fiscal Year Ended September 30, 2025)

---

## Executive Summary

**BLUF: Cabot Corporation demonstrates strong financial health with Adjusted EPS of $7.25 (up 3% YoY) despite challenging macro conditions, generating $665M in operating cash flow with robust margins (22% Adjusted EBITDA margin). However, revenue declined 7% to $3.71B due to volume headwinds from Asian tire imports and weak European construction demand. The company maintains excellent balance sheet metrics (net debt/EBITDA of 1.2x) and strong capital allocation discipline, but FY2026 guidance suggests continued challenges ($6.00-$7.00 Adjusted EPS range). HOLD - Quality company navigating difficult macro environment with disciplined execution.**

---

## Revenue Analysis

### Revenue Performance

| Metric                        | FY2025   | FY2024   | Change   | FY2023   | FY2022   |
|-------------------------------|----------|----------|----------|----------|----------|
| Total Revenue                 | $3,713M  | $3,994M  | -7.0%    | $3,931M  | $4,321M  |
| Revenue Growth (YoY)         | -7.0%    | 1.6%     | --       | -9.0%    | 26.7%    |

**Key Observations:**
- **Revenue Decline:** FY2025 revenue decreased 7.0% to $3.71B, marking the second consecutive year of revenue contraction
- **Volume Impact:** Management cited 8% lower volumes YoY in Q3, driven by:
  - Elevated Asian tire imports into Western markets (particularly Americas)
  - Weaker European construction demand
  - Auto production contraction (third straight year in NA & EU)
- **Segmental Performance:**
  - **Reinforcement Materials:** $2,341M (down 10.3% from $2,610M)
  - **Performance Chemicals:** $1,250M (flat YoY, showing resilience)

### Quarterly Revenue Trends

| Quarter | Q4 FY2025 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q4 FY2024 |
|---------|-----------|-----------|-----------|-----------|-----------|
| Revenue | $899M     | $923M     | $936M     | $955M     | $1,001M   |
| Change QoQ | -2.6%     | -1.4%     | -2.0%     | -4.6%     | --        |

**Trend Analysis:**
- Sequential revenue decline throughout FY2025
- Q4 FY2025 represents lowest quarterly revenue in the period
- Volumes declining across both segments

---

## Profitability Analysis

### Gross Profitability

| Metric                        | FY2025   | FY2024   | Change   | Margin FY2025 | Margin FY2024 |
|-------------------------------|----------|----------|----------|---------------|---------------|
| Gross Profit                  | $940M    | $960M    | -2.1%    | 25.3%         | 24.0%         |
| Cost of Sales                 | $2,773M  | $3,034M  | -8.6%    | 74.7%         | 76.0%         |

**Key Observations:**
- **Gross Margin Expansion:** Despite revenue decline, gross margin improved 130bps to 25.3%
- **Cost Management:** Cost of sales decreased faster than revenue (-8.6% vs -7.0%), demonstrating effective cost controls
- **Efficiency Gains:** Lower raw material costs and operational optimization offset volume declines

### Operating Profitability

| Metric                        | FY2025   | FY2024   | Change   | Margin FY2025 | Margin FY2024 |
|-------------------------------|----------|----------|----------|---------------|---------------|
| Operating Income              | $621M    | $614M    | 1.1%     | 16.7%         | 15.4%         |
| Operating Expenses            | $319M    | $346M    | -7.8%    | 8.6%          | 8.7%          |
| SG&A                          | $260M    | $283M    | -8.1%    | 7.0%          | 7.1%          |
| R&D                           | $59M     | $63M     | -6.3%    | 1.6%          | 1.6%          |

**Key Observations:**
- **Operating Margin Expansion:** Operating margin improved 130bps to 16.7% despite revenue decline
- **Cost Discipline:** Operating expenses decreased 7.8%, outpacing revenue decline
- **Efficiency Metrics:** SG&A as % of revenue improved to 7.0% (vs 7.1% FY2024)

### Segment Profitability

#### Reinforcement Materials

| Metric                        | FY2025   | FY2024   | Change   | Margin FY2025 | Margin FY2024 |
|-------------------------------|----------|----------|----------|---------------|---------------|
| Segment EBIT                  | $508M    | $537M    | -5.4%    | 21.7%         | 20.6%         |
| Segment EBITDA                | $578M    | $603M    | -4.1%    | 24.7%         | 23.1%         |
| Sales                         | $2,341M  | $2,610M  | -10.3%   | --            | --            |

**Key Observations:**
- **EBIT Decline:** Segment EBIT down 5.4% despite volume declines of 8% YoY
- **Margin Resilience:** EBITDA margin improved 160bps to 24.7%, demonstrating strong cost management
- **Volume Impact:** Lower volumes in Americas (-7% Q4) and Asia Pacific (-6% Q4) partially offset by cost reductions

#### Performance Chemicals

| Metric                        | FY2025   | FY2024   | Change   | Margin FY2025 | Margin FY2024 |
|-------------------------------|----------|----------|----------|---------------|---------------|
| Segment EBIT                  | $194M    | $164M    | +18.3%   | 15.5%         | 13.1%         |
| Segment EBITDA                | $278M    | $242M    | +14.9%   | 22.2%         | 19.4%         |
| Sales                         | $1,250M  | $1,250M  | 0.0%     | --            | --            |

**Key Observations:**
- **Strong EBIT Growth:** Segment EBIT increased 18.3% despite flat revenue
- **Margin Expansion:** EBITDA margin improved 280bps to 22.2%
- **Growth Drivers:** Battery materials contribution margin up 20% YoY; growth in wire & cable (+15% YTD) and wind turbine applications (+8% YTD)

### Net Income & EPS

| Metric                        | FY2025   | FY2024   | Change   |
|-------------------------------|----------|----------|----------|
| Net Income (GAAP)             | $331M    | $380M    | -12.9%   |
| Adjusted EPS                  | $7.25    | $7.06    | +2.7%    |
| Diluted EPS (GAAP)            | $6.02    | $6.72    | -10.4%   |

**Key Observations:**
- **Adjusted EPS Growth:** Adjusted EPS increased 2.7% despite challenging environment
- **Certain Items Impact:** GAAP EPS impacted by $1.23 per share in certain items (primarily restructuring, indirect tax settlements, legal matters)
- **Underlying Performance:** Strong operational execution offset volume headwinds

### EBITDA & Margin Analysis

| Metric                        | FY2025   | FY2024   | Change   | Margin FY2025 | Margin FY2024 |
|-------------------------------|----------|----------|----------|---------------|---------------|
| Adjusted EBITDA               | $804M    | $777M    | +3.5%    | 21.7%         | 19.5%         |
| EBITDA                        | $811M    | $761M    | +6.6%    | 21.8%         | 19.1%         |

**Key Observations:**
- **Strong EBITDA Growth:** Adjusted EBITDA increased 3.5% despite 7% revenue decline
- **Significant Margin Expansion:** Adjusted EBITDA margin improved 220bps to 21.7%
- **Operational Excellence:** Demonstrates ability to expand margins through volume declines

---

## Balance Sheet Analysis

### Asset Composition

| Metric                        | 9/30/2025| 9/30/2024| Change   |
|-------------------------------|----------|----------|----------|
| Total Assets                  | $3,815M  | $3,736M  | +2.1%    |
| Current Assets                | $1,539M  | $1,605M  | -4.1%    |
| Cash & Equivalents            | $258M    | $223M    | +15.7%   |
| Accounts Receivable           | $671M    | $733M    | -8.5%    |
| Inventory                     | $504M    | $552M    | -8.7%    |
| Net PPE                       | $1,711M  | $1,534M  | +11.5%   |

**Key Observations:**
- **Asset Growth:** Total assets increased 2.1%, driven by capital investments
- **Working Capital Optimization:** Current assets decreased 4.1% with receivables and inventory down 8.5% and 8.7% respectively
- **Cash Position:** Cash increased 15.7% to $258M, providing strong liquidity
- **Capital Investments:** Net PPE increased 11.5% reflecting strategic investments

### Liability & Equity Structure

| Metric                        | 9/30/2025| 9/30/2024| Change   |
|-------------------------------|----------|----------|----------|
| Total Liabilities             | $2,110M  | $2,146M  | -1.7%    |
| Current Liabilities           | $957M    | $772M    | +24.0%   |
| Long-Term Debt                | $856M    | $1,087M  | -21.3%   |
| Total Debt                    | $1,110M  | $1,228M  | -9.6%    |
| Total Equity                   | $1,705M  | $1,590M  | +7.2%    |
| Retained Earnings             | $1,835M  | $1,734M  | +5.8%    |

**Key Observations:**
- **Debt Reduction:** Total debt decreased 9.6% to $1.11B, with long-term debt down 21.3%
- **Equity Growth:** Total equity increased 7.2% driven by retained earnings growth
- **Current Liabilities Increase:** Current liabilities up 24% primarily due to current portion of long-term debt ($260M vs $8M)

### Financial Health Metrics

| Metric                        | 9/30/2025| 9/30/2024| FY2025   |
|-------------------------------|----------|----------|----------|
| Current Ratio                 | 1.61     | 2.08     | --       |
| Debt/Equity                   | 65.1%    | 77.2%    | --       |
| Net Debt/EBITDA               | 1.2x     | 1.3x     | --       |
| Adjusted ROIC                 | 18%      | --       | --       |

**Key Observations:**
- **Strong Leverage Metrics:** Net debt/EBITDA improved to 1.2x (from 1.3x)
- **Excellent ROIC:** Adjusted ROIC of 18% demonstrates strong capital efficiency
- **Current Ratio:** Declined to 1.61 (from 2.08) but remains healthy, largely due to debt reclassification

---

## Cash Flow Analysis

### Operating Cash Flow

| Metric                        | FY2025   | FY2024   | Change   |
|-------------------------------|----------|----------|----------|
| Operating Cash Flow           | $665M    | $692M    | -3.9%    |
| Net Income                    | $376M    | $424M    | -11.3%   |
| Depreciation & Amortization   | $154M    | $151M    | +2.0%    |
| Working Capital Changes       | $56M     | $57M     | -1.8%    |
| Free Cash Flow                | $391M    | $451M    | -13.3%   |
| Discretionary Free Cash Flow  | $447M    | --       | --       |

**Key Observations:**
- **Strong Operating Cash Flow:** $665M operating cash flow remains robust despite earnings decline
- **Cash Conversion:** Strong cash conversion with operating cash flow 1.77x net income
- **Working Capital Efficiency:** Positive working capital changes of $56M reflect efficient capital management
- **Free Cash Flow:** $391M free cash flow, down 13.3% but still substantial

### Capital Allocation

| Metric                        | FY2025   | FY2024   | Change   |
|-------------------------------|----------|----------|----------|
| Capital Expenditures          | $274M    | $241M    | +13.7%   |
| Dividends Paid                | $96M     | $93M     | +3.2%    |
| Share Repurchases             | $168M    | $172M    | -2.3%    |
| Total Shareholder Returns     | $264M    | $265M    | -0.4%    |
| Acquisitions                  | $27M     | $0M      | --       |

**Key Observations:**
- **Increased CapEx:** Capital expenditures increased 13.7% to $274M, reflecting strategic investments
- **Consistent Dividends:** Dividends increased 3.2% (5% increase announced in May)
- **Share Repurchases:** $168M in share repurchases, maintaining strong capital return
- **Strategic M&A:** $27M acquisition (Bridgestone Mexico plant)

### Cash Position

| Metric                        | 9/30/2025| 9/30/2024| Change   |
|-------------------------------|----------|----------|----------|
| Cash & Equivalents            | $258M    | $223M    | +15.7%   |
| Liquidity Available          | $1.5B    | ~$1.4B   | --       |
| Net Debt                      | $852M    | $917M    | -7.1%    |

**Key Observations:**
- **Strong Liquidity:** $1.5B total liquidity provides significant financial flexibility
- **Improving Net Debt:** Net debt decreased 7.1% despite acquisitions
- **Cash Generation:** Strong cash generation supports capital allocation priorities

---

## Key Financial Ratios

### Profitability Ratios

| Metric                        | FY2025   | FY2024   | FY2023   |
|-------------------------------|----------|----------|----------|
| Gross Margin                  | 25.3%    | 24.0%    | 21.3%    |
| Operating Margin              | 16.7%    | 15.4%    | 13.5%    |
| Net Margin (Adjusted)         | 11.2%    | 10.6%    | 11.4%    |
| EBITDA Margin (Adjusted)      | 21.7%    | 19.5%    | 17.7%    |
| Return on Assets              | 10.9%    | --       | --       |
| Return on Equity              | 29.4%    | --       | --       |
| Return on Invested Capital    | 18.0%    | --       | --       |

**Key Observations:**
- **Margin Expansion Trend:** Consistent margin expansion across all metrics over 3-year period
- **Strong Returns:** ROE of 29.4% and ROIC of 18.0% demonstrate excellent capital efficiency
- **Operational Excellence:** Margin expansion despite revenue headwinds shows strong execution

### Efficiency Ratios

| Metric                        | FY2025   | FY2024   | Change   |
|-------------------------------|----------|----------|----------|
| Asset Turnover                | 0.97x    | 1.07x    | -9.3%    |
| Inventory Turnover            | 5.5x     | 5.5x     | 0.0%     |
| Days Sales Outstanding        | 64 days  | 67 days  | -4.5%    |
| Days Inventory Outstanding    | 66 days  | 66 days  | 0.0%     |

**Key Observations:**
- **Asset Efficiency:** Asset turnover declined with revenue decline, but inventory management remains efficient
- **Working Capital Management:** Days sales outstanding improved, reflecting better receivables management

---

## Valuation Metrics

| Metric                        | Current  | FY2025   |
|-------------------------------|----------|----------|
| Market Cap                    | $4.02B   | --       |
| Enterprise Value              | $5.00B   | --       |
| Trailing P/E                  | 9.90x    | --       |
| Forward P/E                   | 9.94x    | --       |
| Price/Sales                   | 1.08x    | --       |
| Price/Book                    | 2.61x    | --       |
| EV/Revenue                    | 1.31x    | --       |
| EV/EBITDA                     | 6.16x    | --       |

**Key Observations:**
- **Attractive Valuation:** Trading at discounted multiples relative to historical levels
- **P/E Compression:** Trailing P/E of 9.90x reflects market concerns about macro headwinds
- **EV/EBITDA:** Trading at 6.16x EV/EBITDA, reasonable for specialty chemicals company

---

## Financial Outlook

### Fiscal Year 2026 Guidance

| Metric                        | Guidance Range |
|-------------------------------|----------------|
| Adjusted EPS                  | $6.00 - $7.00 |
| Interest Expense              | ($73M) - ($77M)|
| Capital Expenditures          | $200M - $250M  |
| Share Repurchases             | $100M - $200M  |
| Operating Tax Rate            | 27% - 29%      |

**Key Observations:**
- **Challenging Outlook:** Adjusted EPS guidance of $6.00-$7.00 implies potential decline from FY2025
- **Continued Disciplined CapEx:** CapEx guidance of $200M-$250M reflects continued strategic investments
- **Capital Return:** Share repurchase guidance of $100M-$200M maintains shareholder returns

---

## Strengths

1. **Strong Margin Expansion:** Adjusted EBITDA margin improved 220bps to 21.7% despite revenue decline
2. **Excellent Cash Generation:** $665M operating cash flow provides strong financial flexibility
3. **Disciplined Capital Allocation:** Balanced approach to growth investments, M&A, and shareholder returns
4. **Balance Sheet Strength:** Net debt/EBITDA of 1.2x and $1.5B liquidity provide financial resilience
5. **Operational Excellence:** Strong cost management and optimization efforts offsetting volume headwinds

## Concerns

1. **Revenue Declines:** Second consecutive year of revenue contraction, down 7% in FY2025
2. **Volume Headwinds:** 8% volume decline driven by Asian tire imports and weak European demand
3. **Outlook Uncertainty:** FY2026 guidance suggests continued challenges
4. **Segment Divergence:** Reinforcement Materials facing structural headwinds while Performance Chemicals shows strength
5. **Macro Sensitivity:** Exposure to auto production and construction markets experiencing weakness

---

## Conclusion

Cabot Corporation demonstrates strong financial discipline and operational excellence, generating robust cash flows and expanding margins despite challenging macroeconomic conditions. The company's ability to offset volume declines through cost management and optimization is impressive. However, revenue headwinds from Asian tire imports and weak European construction demand present ongoing challenges. The strong balance sheet, excellent cash generation, and disciplined capital allocation provide resilience, but the FY2026 outlook suggests continued pressure. The company's quality execution and financial strength position it well for long-term value creation, but near-term headwinds require monitoring.

**Recommendation:** HOLD - Quality company navigating difficult macro environment with disciplined execution. Suitable for investors seeking exposure to specialty chemicals with strong financial metrics and capital allocation discipline, but with tolerance for near-term volume headwinds.
